Users can connect data from their medical records and wellness apps so the popular chatbot can walk them through test results or compare insurance options. Still, OpenAI stressed that ChatGPT Health is not a replacement for a doctor.
The DC-based biopharma disputed the FDA’s conclusions regarding the data provided in its supplemental application for Hetlioz and promised to keep pushing for an approval.
Vanda Slides After FDA Again Rejects Hetlioz For Jet Lag Read More »
From insurance coverage questions to M&A and tariffs, here are the top storylines to watch in the medical device space in 2026.
The regulator clarified the types of wellness features and clinical decision support tools that don’t fall under medical device oversight in a pair of new guidance documents.
FDA exempts more wearable, AI features from oversight Read More »
In a pair of guidance documents released Tuesday, the regulator clarified the types of wellness features and clinical decision support tools that don’t fall under medical device oversight.
FDA exempts more wearable, AI features from oversight Read More »
Health systems that use the current environment to address costs, workforce planning and portfolio strategy may be better positioned as reimbursement headwinds intensify.
En los procesos de adopción tecnológica, uno de los principales frenos para las empresas no es la falta de interés, sino el miedo a que la tecnología no funcione como se promete. En este contexto, las garantías de funcionamiento se convierten en un factor decisivo. …
Garantías de funcionamiento y su impacto en la adopción empresarial local Read More »
En la restauración actual, donde la rapidez y la eficiencia son tan importantes como la calidad de la comida, la cuestión ya no es si la tecnología es útil, sino cómo aprovecharla de forma efectiva. Los menús digitales inteligentes para autoservicio son u …
Mayor precisión en los pedidos con los menús digitales inteligentes para autoservicio Read More »
While venture capital funding dipped to a six-year low in 2025, it nevertheless remained above pre-pandemic levels for Massachusetts-based biopharma companies, according to MassBio.
VC Funding Uptick in Back Half of 2025 Has Analysts Hopeful for 2026 Read More »
A bevy of other companies also brought in money on Thursday, including Alveus Therapeutics, Diagonal Therapeutics, EpiBiologics, Beacon Therapeutics and Protege.
Parabilis Heads Biotech Fundraising Frenzy With $305M to Advance Cancer Drug Read More »
